Key Financial Data Of Reporting Company

ROHTO PHARMACEUTICAL CO.,LTD. - Filing #7295708

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
139,082,000,000 JPY
270,840,000,000 JPY
127,869,000,000 JPY
Ordinary profit (loss)
18,590,000,000 JPY
42,434,000,000 JPY
22,678,000,000 JPY
Net assets
264,347,000,000 JPY
247,036,000,000 JPY
238,800,000,000 JPY
Total assets
408,260,000,000 JPY
346,175,000,000 JPY
334,957,000,000 JPY
Basic earnings (loss) per share
56.64
135.61
72.74
Diluted earnings per share
56.47
135.21
72.53
Equity-to-asset ratio
0.619 xbrli:pure
0.710 xbrli:pure
0.694 xbrli:pure
Net cash provided by (used in) operating activities
14,007,000,000 JPY
34,245,000,000 JPY
8,811,000,000 JPY
Net cash provided by (used in) investing activities
-83,525,000,000 JPY
-16,317,000,000 JPY
-8,351,000,000 JPY
Net cash provided by (used in) financing activities
40,297,000,000 JPY
-13,784,000,000 JPY
-4,902,000,000 JPY
Cash and cash equivalents
61,278,000,000 JPY
86,562,000,000 JPY
76,970,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.